ABSTRACT
Description: Ecokinase is a recombinant, nonglycosylated, modified form of human tissue plasminogen activator (tPA). It is produced in Escherichia coli by recombinant DNA technology and is presented in a lyophilized form to be reconstituted before intravenous administration using a solvent-filled syringe. (See also the monograph for the product Rapilysin, which contains the same active ingredient.)
Approval Date:
1996 (E.U.)
Withdrawal Date:
Therapeutic Indications:
Ecokinase was indicated in the thrombolytic therapy of acute myocardial infarction.
